Today's Fed Action Faces Lots of Headwinds<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />12/11/2007 8:12 AM EST<br /><br /><br />Most of life is choices, and the rest is pure dumb luck. <br />-- Marian Erickson<br /> <br />Today at 2:15 p.m. EST, the Federal Open Market Decision will announce whether it will cut interest rates once again. A cut is widely anticipated, but observers are pretty evenly split over whether it will be a quarter- or a half-point trim. <br /><br />Is the Fed action going to boost the market further or trigger a new round of selling? The market has been rallying sharply for three weeks now, and there is no question that part of the reason is anticipation that the Fed is going to take further steps to bolster liquidity and save us from the subprime contagion. <br /><br />The current rally was helped by a proposed mortgage bailout program that freezes "teaser rates" for a select group, but the market has began to dismiss that as a political ploy without any real meaning and has once again looked to the Fed to provide a better solution. <br /><br />Many economists question whether the Fed really has the capacity to halt the massive subprime writedowns that continue to flow. UBS (UBS ) and Washington Mutual (WM ) are the latest to take hits, foreshadowing billions more in similar writedowns by other financial institutions. <br /><br />The Fed move today faces plenty of headwinds. Not only is it highly anticipated, but many wonder whether it really is going to solve our problems and help stave off the recession that many in the financial world feel is increasingly likely. <br /><br />The good news is that we have some upside momentum in recent trading, and positive seasonality seems to be aiding the mood. Once again, the bears find themselves with plenty of great arguments for why this market should fall apart but find themselves being squeezed when no one listens. <br /><br />The big danger the bulls face right now is complacency. It is quite easy to assume we are just going to keep on rallying in the face of these massive negatives simply because the Fed is cutting rates and we are wrapping up the year. We have to stay aware that this strength is very fragile and that the Fed can easily serve as a trigger for a new round of selling if expectations are not met. <br /><br />I don't know how things will play out following the Fed decision (we will discuss some scenarios later), but I do know that trying to bet on how the market reacts is a major gamble with little edge. <br /><br />We have a positive start this morning -- good news from Texas Instruments (TXN ) is offsetting bad news from Washington Mutual. Overseas markets were mixed, with Asia up and Europe down. Oil is bouncing and gold is down slightly. <br /><br /><br />----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ARM +15.6%, SVA +11.6%, FCEL +9.8%, NPD +5.2%, SAI +4.8% (also upgraded to Buy at Jefferies), TXN +4.5%, ENZ +4.0%, PRGO +2.7% (also announces final FDA approval of Dexcel's OTC Omeprazole), MGAM +2.3%, DMND +1.6%, WEN +1.2% (co expects to report FY07 EPS near the high end of the range provided earlier), MTL +1.2% (reports 9 month results)... M&A news: GNSS +57.6% (STM to acquire GNSS for $8.65/share), TRID +5.9% and ZRAN +1.9% (in sympathy)... Other news: SMSI +14.1% (buys Mobility Solutions Group for $59.7 mln from PCTI), NFI +9.8% (notes in an 8-K that the co has entered into a Master Repurchase Agreements Waiver), CTIC +9.4% (announces prelim results for Pixantrone vs doxorubicin for aggressive NHL), GY +7.0% (awarded $62 mln for U.S. Air Force's F-22 raptor program), GTS +5.5% (Cramer highlights stock on MadMoney), TLCV +3.9% (Highland Capital discloses 18.67% stake in SC 13D/A), LSCC +3.2% (Soros Fund Mgmt discloses 5.19% stake in SC 13G), WCG +2.9% (received an executed amendment number 2 to the current Medical Services Agreement; co also notes that Fairholme Capital reports a 16.1% stake in a SC 13G), RFMD +2.8% (still checking), PAY +2.6% (still checking), AEM +2.4% (increases annual cash dividend by 50% and provides updates in reserves and production), ANSS +2.4% (Cramer makes positive comments on MadMoney), TRMS +2.3% (announces 2008 strategic plan; designed to maximize cash flows from FUZEON, while also advancing TRI-1144 to a value-creating milestone), TDY +2.0% (Cramer makes positive comments on MadMoney), CELG +1.9% (Cramer makes positive comments on MadMoney, also announces Revlimid with rituximab demonstrates 70% response rate in relapsed/refractory mantle cel lymphoma), T +1.8% (announces a 400 mln share buyback; increases qtrly dividend to $0.40 from $0.355), GIGM +1.2% (announces investment in XLGames)... Analyst upgrades: EBAY +2.4% (added to Recommended List at Citigroup), BKC +2.2% (hearing upgraded to Buy at tier-1 firm), MA +1.3% (upgraded to Outperform at Keefe, Bruyette), RRI +1.0% (upgraded to Neutral at BofA).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: NCS -14.0%, HRB -7.3% (also files to delay 10-Q, expects to file by Friday), PLL -6.2% (gives preliminary results but also files to delay in NT 10-Q), GNW -3.9% (issues 2007 goals in slides and FY08 EPS guidance below consensus), GGP -3.1%, IDT -1.0%... Other news: PANC -18.7% (announces results of Bevirimat, data support further dose escalation in phase 2b study; also downgraded to Outperform at Cowen), MEDX -17.6% (announces data from ipilimumab pivotal trials for metastatic melanoma did not meet primary endpoint; also downgraded to Peer Perform at Bear Sterns), WM -7.9% (raises $2.5 bln in additional Capital, reduces dividend, resizes home loans business and cuts expenses to Fortify Capital Base; also JPM may consider buying WM according to Punk Ziegel- Bloomberg), RTP -3.1% (challenged BHP to make a formal bid), UBS -2.6% (multiple stories out this morning after yesterday's capital raise; stock also down despite being upgraded at Bear Stearns), NVS -1.8% (plans restructuring - WSJ), EDE -1.8% (announces extension of Asbury Plant outage after unit failed inspection), SI -1.6% (still checking), TMA -1.6% (files Form S-3 announcing the offer and sale of common stock)... Analyst downgrades: VIP -2.3% (downgraded to Underperform at Bear Sterns), DFS -1.6% (downgraded to Market Perform at Keefe, Bruyette), SBUX -1.4% (downgraded to Equal Weight at Lehman), STI -1.2% (downgraded to Mkt Perform at Keefe, Bruyette).